Chinese drug developer Abbisko files for HK IPO Larissa Ku PE-backed Abbisko Therapeutics, which focuses on the discovery and development of innovative and differentiated small molecule oncology therapies, has filed for a Hong Kong IPO. The largest institutional shareholder is Lilly Asia Ventures (LAV) with an 11.16% stake, followed by Qiming Venture Partners and Elbrus Investments, a subsidiary of Temasek Holdings, with 8.65% and 8.28%,…
News Timeline:
Track the development of related news across the Internet.
February 9, 2026
18:09
Source: independent.ie
February 9, 2026
18:06
Source: ndtv.com
January 14, 2026
18:27
Source: thedailybeast.com
November 20, 2025
05:42
Source: ajc.com
November 20, 2025
05:20
Source: wtop.com
November 13, 2025
05:38
Source: economictimes.indiatimes.com
October 17, 2025
14:50
Source: ChinaMoneyNetwork.com
September 3, 2025
17:47
Source: theguardian.com
June 20, 2025
02:01
Source: castanet.net
April 4, 2025
21:35
Source: theguardian.com